Protective efficacy of malaria case management and intermittent preventive treatment for preventing malaria mortality in children: a systematic review for the Lives Saved Tool
Open Access
- 1 January 2011
- journal article
- research article
- Published by Springer Nature in BMC Public Health
- Vol. 11 (Suppl 3) , S14
- https://doi.org/10.1186/1471-2458-11-s3-s14
Abstract
The Lives Saved Tool (LiST) model was developed to estimate the impact of the scale-up of child survival interventions on child mortality. New advances in antimalarials have improved their efficacy of treating uncomplicated and severe malaria. Artemisinin-based combination therapies (ACTs) for uncomplicated Plasmodium falciparum malaria and parenteral or rectal artemisinin or quinine for severe malaria syndromes have been shown to be very effective for the treatment of malaria in children. These interventions are now being considered for inclusion in the LiST model. However, for obvious ethical reasons, their protective efficacy (PE) compared to placebo is unknown and their impact on reducing malaria-attributable mortality has not been quantified.Keywords
This publication has 82 references indexed in Scilit:
- Artesunate versus quinine in the treatment of severe falciparum malaria in African children (AQUAMAT): an open-label, randomised trialThe Lancet, 2010
- Standards for CHERG reviews of intervention effects on child survivalInternational Journal of Epidemiology, 2010
- Artemisinin-based combination therapy for treating uncomplicated malariaCochrane Database of Systematic Reviews, 2009
- A Trial of Combination Antimalarial Therapies in Children from Papua New GuineaNew England Journal of Medicine, 2008
- Rectal Administration of Artemisinin Derivatives for the Treatment of MalariaJAMA, 2007
- Combination Therapy for Uncomplicated Falciparum Malaria in Ugandan ChildrenJAMA, 2007
- Dihydroartemisinin-Piperaquine versus Artesunate-Amodiaquine: Superior Efficacy and Posttreatment Prophylaxis against Multidrug-Resistant Plasmodium falciparum and Plasmodium vivax MalariaClinical Infectious Diseases, 2007
- Two fixed-dose artemisinin combinations for drug-resistant falciparum and vivax malaria in Papua, Indonesia: an open-label randomised comparisonThe Lancet, 2007
- Association of Transmission Intensity and Age With Clinical Manifestations and Case Fatality of Severe Plasmodium falciparum MalariaJAMA, 2005
- Artemisinin derivatives for treating severe malariaCochrane Database of Systematic Reviews, 1998